Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery disease
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Cardiovascular Electrophysiology"
DOI: 10.1111/jce.14335
Abstract: Class 1C antiarrhythmic drugs (AADs) are effective first‐line agents for atrial fibrillation (AF) treatment. However, these agents commonly are avoided in patients with known coronary artery disease (CAD), due to known increased risk in the… read more here.
Keywords: atrial fibrillation; class antiarrhythmic; coronary artery; antiarrhythmic drugs ... See more keywords